Literature DB >> 719249

The effect of SQ 14225 on fluid intake in DOCA/salt hypertensive rats [proceedings].

H G Dean, S Ingham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 719249      PMCID: PMC1668526     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.

Authors:  R J Laffan; M E Goldberg; J P High; T R Schaeffer; M H Waugh; B Rubin
Journal:  J Pharmacol Exp Ther       Date:  1978-02       Impact factor: 4.030

2.  Sodium chloride suppression of renin release in the unanesthetized rat.

Authors:  W B Campbell; W A Pettinger
Journal:  Endocrinology       Date:  1975-12       Impact factor: 4.736

3.  A specific orally active inhibitor of angiotensin-converting enzyme in man.

Authors:  R K Ferguson; G A Turini; H R Brunner; H Gavras; D N McKinstry
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

  3 in total
  3 in total

Review 1.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

2.  Involvement of the renin-angiotensin system in captopril-induced sodium appetite in the rat.

Authors:  R M Elfont; A N Epstein; J T Fitzsimons
Journal:  J Physiol       Date:  1984-09       Impact factor: 5.182

Review 3.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.